Talis Biomedical Corporation Operating Lease Cost
Talis Biomedical Corporation reported Operating Lease Cost of $6.63 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-03-28
- Talis Biomedical Corporation operating lease, cost for the quarter ending 2022-12-31 was $1.17M, a 74.29% increase year-over-year.
- Talis Biomedical Corporation operating lease, cost for the quarter ending 2022-09-30 was $1.28M, a 93.82% increase year-over-year.
- Talis Biomedical Corporation operating lease, cost for the quarter ending 2022-06-30 was $913.00K, a 91.00% increase year-over-year.
- Talis Biomedical Corporation operating lease, cost for the quarter ending 2021-12-31 was $673.00K.
- Talis Biomedical Corporation operating lease, cost for fiscal 2023 was $6.63M, a 61.83% increase from fiscal 2022.
- Talis Biomedical Corporation operating lease, cost for fiscal 2022 was $4.10M, a 106.65% increase from fiscal 2021.
- Talis Biomedical Corporation operating lease, cost for fiscal 2021 was $1.98M, a 216.93% increase from fiscal 2020.
- Talis Biomedical Corporation operating lease, cost for fiscal 2020 was $626.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.63M 10-K · filed 2024-03-28 | |||
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.46M derived: sum of 2 quarters · filed 2024-03-28 | $3.37M derived: sum of 3 quarters · filed 2024-03-28 | $4.10M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.28M 10-Q · filed 2022-11-03 | $2.20M derived: sum of 2 quarters · filed 2022-11-03 | $2.93M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $913.00K 10-Q · filed 2022-08-02 | $1.59M 10-Q · filed 2022-08-02 | ||
| 2021-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.34M derived: sum of 2 quarters · filed 2023-03-22 | $1.81M derived: sum of 3 quarters · filed 2023-03-22 | $1.98M 10-K · filed 2023-03-22 |
| 2021-09-30 | $663.00K 10-Q · filed 2022-11-03 | $1.14M derived: sum of 2 quarters · filed 2022-11-03 | $1.31M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $478.00K 10-Q · filed 2022-08-02 | $648.00K 10-Q · filed 2022-08-02 | ||
| 2020-12-31 | $626.00K 10-K · filed 2022-03-15 |